General practitioner and senior researcher Erik Bischoff of the Department of Primary and Communicaty Care received a ZonMw grant of 250K for his project ‘A whole system multimorbidity approach to improve patient centred chronic disease management in primary care’ (in Dutch ‘Ketenzorg Ontketend’).Objectives of this project are (i) to develop, in close collaboration with patients and healthcare professionals, a primary care whole-system patient centred multimorbidity management programme as a substitute for the current separate chronic disease management programmes for Diabetes Mellitus type 2, Chronic Obstructive Pulmonary Disease (COPD) and Cardiovascular Diseases, (ii) to test its feasibility and to optimise it, and (iii) to evaluate the effects and costs. Erik: “There is an urgent need for a complete new organisation of primary care chronic disease management among all stakeholders, i.e. patients, healthcare professionals , health policy makers and health insurance companies. The impact of chronic diseases and multimorbidity in particular on our society is high and rapidly increasing, but the current healthcare organisation is ineffective and inefficient. In our project we will guide healthcare professionals and patients in the process of developing their own regional chronic disease management programme that puts the individual patient with all his morbidities at the centre of care and not a single disease and that responds to the needs and the context of the patient to provide the right care in the right place at the right time. Specific attention will be paid to training, ICT support and financing. Our results will have significant impact on how chronic disease management will be organised in the nearby future.
Erik Bischoff is member of theme Inflammatory diseases.
Related news items
Rectal cancer staging using MRI with endorectal filling19 September 2018
In the British Journal of Radiology Rutger Stijns and colleagues, showed that using MRI with endorectal filling did not lead to an improved rectal cancer staging and that it has the potential to influence the distance to a key anatomical landmark.read more
Low risk of progression in persistent non-dysplastic Barrett’s esophagus19 September 2018
In Clinical Gastroenterology and Hepatology Peter Siersema and Yonne Peters showed that patients with stable persistence of non-dysplastic Barrett’s esophagus have a low risk of malignant progression and may not benefit from routine endoscopic surveillance.read more